StockWatch
·
Pharmaceuticals
Board Meeting25 Aug 2026, 07:20 pm

Vineet Laboratories Approves Audited FY26 Standalone Financial Results

AI Summary

Vineet Laboratories Ltd announced that its Board of Directors, in a meeting held on August 25, 2026, approved the Audited Standalone Financial Results for the fourth quarter and the financial year ended March 31, 2026. The company also approved the Audited Standalone Financial Statement for the fiscal year along with the Audit Report. The auditors, NSVR & Associates LLP, issued an unmodified opinion. The company also disclosed details of outstanding and incremental qualified borrowings for FY25 and FY26, confirming it is not a 'Large Corporate' as per SEBI regulations. The board meeting took place from 3:00 PM to 6:30 PM.

Key Highlights

  • Board approved audited standalone financial results for Q4 and FY26.
  • Audited standalone financial statement for FY26 also approved.
  • Statutory auditors issued an unmodified audit opinion.
  • Disclosure on qualified borrowings for FY25 and FY26 provided.
  • Company confirmed it is not classified as a 'Large Corporate'.